What science says about Amygdalin / Vitamin B17 For Cancer

Amygdalin, a naturally occurring compound primarily found in the seeds of fruits like apricots and bitter almonds, has gained attention in the context of cancer treatment. Advocates suggest that amygdalin (vitamin B17) for cancer, often referred to as "laetrile," can selectively target cancer cells and may serve as a complementary approach to conventional therapies. However, the scientific community is divided on this topic.

Critics point to the lack of robust clinical evidence supporting its efficacy and highlight significant concerns regarding potential cyanide poisoning resulting from the compound's metabolism in the body. Furthermore, some proponents argue that the medical industry may resist the promotion of amygdalin due to its affordability, which threatens the profitability of conventional cancer treatments.

Supporting Views for Amygdalin (Vitamin B17) for Cancer

Supporters of amygdalin emphasize several potential benefits. They argue that the compound may selectively kill cancer cells while sparing healthy ones, a claim supported by some animal studies conducted by researchers like Dr. Kanematsu Sugiura, which suggest a potential inhibitory effect on tumor growth. Many patients have also reported pain relief associated with amygdalin use, enhancing their overall quality of life during treatment. Furthermore, advocates believe that amygdalin may bolster immune function, helping the body combat cancer more effectively. Some supporters contend that the pharmaceutical industry opposes amygdalin because its low cost and potential efficacy threaten the profitability of more expensive cancer treatments, leading to skepticism regarding conventional medical practices.

Opinion Opposing Amygdalin (Vitamin B17) for Cancer

Critics of amygdalin raise several important concerns regarding its use in cancer treatment. The most significant issue is the lack of substantial scientific evidence supporting its efficacy. Organizations such as the American Cancer Society have clearly stated that no reliable studies confirm amygdalin as an effective cancer treatment. Additionally, there are serious toxicity concerns, as amygdalin can metabolize into cyanide in the body, posing significant health risks. Documented cases of cyanide poisoning have raised alarms, particularly when amygdalin is consumed in high doses or as unregulated supplements. Health authorities, including the FDA, have also issued warnings against using amygdalin for cancer treatment, emphasizing the absence of adequate clinical evidence and the associated risks.

Disclaimer: The information in this article is based on research and published medical sources. It is provided for educational purposes only, and is not intended to replace professional medical advice. Always consult with your doctor or healthcare provider regarding any questions you may have about your health. We are not responsible for any actions taken based on the information in this article.

October 2024
AposBook